NCT00426296Unknown4 期
An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of a Fixed-Dose Combination of Abacavir 600 mg/Lamivudine 300 mg Once-Daily in Combination With Atazanavir 300 mg + Ritonavir 100 mg Once-Daily in Antiretroviral-Naïve HIV-1 Infected Subjects With Continuing Evaluation of Abacavir/Lamivudine Plus Atazanavir 400 mg for Maintenance Over an Additional 48 Weeks
Clinical Alliance for Research & Education - Infectious Diseases, LLC.2 个研究点 分布在 1 个国家开始时间: 2006年8月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 发起方
- 试验地点
- 2
研究概览
简要总结
SHARE: Simple HAART with Abacavir, Reyataz, and Epivir
详细描述
Open-label, multicenter study of ABC/3TC + ATV in subjects who have completed at least 24 weeks of treatment on ABC/3TC+ATV/RTV as their first line regimen and have plasma HIV-1 RNA <50 copies/mL at entry
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Currently taking abacavir/lamivudine (Epzicom) in combination with atazanavir (Reyataz) boosted with ritonavir (Norvir) as first antiretroviral regimen
- •Viral load <50 copies/ml
排除标准
- •Viral load >50 copies/ml
- •Having taken more than one antiretroviral regimen
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 PatientsHIV-1 InfectionNCT01989910Taipei Veterans General Hospital, Taiwan107
已完成
3 期
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus InfectionHepatitis C Virus (HCV)NCT02609659AbbVie105
已完成
2 期
ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected PatientsChronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1NCT01464827AbbVie (prior sponsor, Abbott)580
已完成
3 期
A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) InfectionChronic Hepatitis C Virus (HCV) InfectionNCT02216422AbbVie36
已完成
3 期
A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected AdultsHepatitis C InfectionHepatitis C VirusNCT02582632AbbVie166